http://www.protaratx.com
Protara Therapeutics, Inc. Company Intro
Steadfast and tenacious in our search for transformative therapies TARA-002 for Lymphatic Malformations TARA-002 is an investigational cell therapy based on the approved broad immunostimulant OK-432, which is approved in Japan and Taiwan for lymphatic malformations. read more IV Choline Chloride ...
Industry
Healthcare
Protara Therapeutics, Inc. Headquaters
1 Little West 12th Street
New York,10014
United States
Protara Therapeutics, Inc. Share price
17 May 2023 13:58 GMT
$3.3900
-0.1 (-2.87 %)
Protara Therapeutics, Inc. Market cap
$39.691 M
WMC RANKING
2023
Protara Therapeutics, Inc. # 514
BiotechnologyLatest Protara Therapeutics, Inc. News
20 Sep 2023
Protara Therapeutics Announces Dosing of First Patient in Phase 1b/2 ADVANCED-2 Trial of TARA-002 in NMIB
NEW YORK, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (NASDAQ:TARA), a clinical-stage company developing transformative therapies for the...
19 Sep 2023
Elutia shares skyrocket on divestiture of Orthobiologics business (NASDAQ:ELUT)
Elutia (ELUT) said on Tuesday that it had sold its Orthobiologics business unit to Berkeley Biologics, a unit of GNI Group.Shares of ELUT soared 28.2% in...
19 Sep 2023
Elutia shares skyrocket on divestiture of Orthobiologics business (NASDAQ:ELUT)
Elutia (ELUT) said on Tuesday that it had sold its Orthobiologics business unit to Berkeley Biologics, a unit of GNI Group.Shares of ELUT soared 28.2% in...
WMC Market Score
WMC Market to Revenue Score
Protara Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Protara Therapeutics, Inc. | USD | $0 | $37,864 | $-37,383 | $397M | 514 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $144,340B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Protara Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Protara Therapeutics, Inc. Post vs Top 4 Industry Competitors
Protara Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Protara Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Protara Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Protara Therapeutics, Inc. | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 28 | 0 | 0 | 29.94 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 40 | 0 | 0 | 36.32 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 32 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 45.31 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
